2017, Volume 3, Issue 1
Engineering >> 2017, Volume 3, Issue 1 doi: 10.1016/J.ENG.2017.01.006
Whether Probiotic Supplementation Benefits Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis
a State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China
b Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China
Next Previous
Abstract
Gut and oral microflora are important factors in the pathogenesis and development of rheumatoid arthritis (RA). Recent studies have shown that probiotic supplements have beneficial consequences on experimental arthritis in rats. However, results from randomized clinical trials on the effects of probiotics have not been consistent. The aim of this study was to systematically review the existing evidence for the effects of probiotic intervention in RA. We included randomized controlled trials (RCTs) of RA patients receiving stable treatment with disease-modifying anti-rheumatic drugs (DMARDs) that: ① were combined with additional probiotic supplements or ② were combined with either no additional supplements or only a placebo treatment. Statistical analysis was performed using Review Manager 5.3.3. Six randomized clinical trials were eligible for inclusion in the meta-analysis, with 249 participants in total. The results showed that the probiotic intervention treatment has not yet achieved significant improvement in the American College of Rheumatology 20% improvement criteria (ACR20) score and the disease activity score in 28 joints (DAS28). The laboratory index C-reactive protein (CRP) (mg·L−1) was significantly reduced in the intervention group. The expression of inflammatory cytokines tumor necrosis factor (TNF)-α and interleukine (IL)-1β was also significantly reduced, while IL-10 expression increased in the probiotic intervention groups. This article is the first systematic review and meta-analysis providing a comprehensive assessment of the benefits of treating RA with probiotics. We found that probiotic supplementation may show a limited improvement in RA therapy in existing reports because of a lack of sufficiently high-quality work on the part of clinicians. More multi-centered, large-sample RCTs are needed in order to evaluate the benefits of probiotics in RA treatment.
Keywords
Rheumatoid arthritis ; Intervention ; Probiotic supplementation ; Systematic review ; Meta-analysis
SupplementaryMaterials
Figures
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
References
[ 1 ] Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423(6937):356–61 link1
[ 2 ] Mikuls TR. Co-morbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17(5):729–52 link1
[ 3 ] Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al.The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 2015;21(8):895–905 link1
[ 4 ] Kennedy RJ, Kirk SJ, Gardiner KR. Probiotics (Br J Surg 2001; 88: 161–2). Br J Surg 2001;88(7):1018–9 link1
[ 5 ] O’Toole PW, Cooney JC. Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip Perspect Infect Dis 2008;2008:175285 link1
[ 6 ] Shinkai S, Toba M, Saito T, Sato I, Tsubouchi M, Taira K, et al.Immunoprotective effects of oral intake of heat-killed Lactobacillus pentosus strain b240 in elderly adults: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2013;109(10):1856–65 link1
[ 7 ] Shokryazdan P, Faseleh Jahromi M, Navidshad B, Liang JB. Effects of prebiotics on immune system and cytokine expression. Med Microbiol Immunol.Epub 2016 Oct 4 link1
[ 8 ] Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohn’s Colitis 2014;8(12):1569–81 link1
[ 9 ] Amdekar S, Roy P, Singh V, Kumar A, Singh R, Sharma P. Anti-inflammatory activity of Lactobacillus on carrageenan-induced paw edema in male Wistar rats. Int J Inflamm 2012;2012:752015 link1
[10] Amdekar S, Singh V, Kumar A, Sharma P, Singh R. Lactobacillus casei and Lactobacillus acidophilus regulate inflammatory pathway and improve antioxidant status in collagen-induced arthritic rats. J Interf Cytok Res 2013;33(1):1–8 link1
[11] Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et alThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31(3):315–24 link1
[12] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535 link1
[13] Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et alAssessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17(1):1–12 link1
[14] Pineda Mde L, Thompson SF, Summers K, de Leon F, Pope J, Reid G. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit 2011;17(6):CR347–54 link1
[15] Vaghef-Mehrabany E, Alipour B, Homayouni-Rad A, Sharif SK, Asghari-Jafarabadi M, Zavvari S. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 2014;30(4):430–5 link1
[16] Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, et alEffects of probiotic therapy on the activity and activation of mild rheumatoid arthritis?a pilot study. Scand J Rheumatol 2003;32(4):211–5 link1
[17] Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M, et alEffects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis 2014;17(5):519–27 link1
[18] Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med 2010;10:1 link1
[19] Zamani B, Golkar HR, Farshbaf S, Emadi-Baygi M, Tajabadi-Ebrahimi M, Jafari P, et alClinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int J Rheum Dis 2016;19(9):869–79 link1
[20] Gul’neva MIu, Noskov SM. Colonic microbial biocenosis in rheumatoid arthritis. Klin Med 2011;89(4):45–8 link1
[21] Newland PK, Heitkemper M, Zhou Y. The emerging role of the gut microbiome in adult patients with multiple sclerosis. J Neurosci Nurs 2016;48(6):358–64 link1
[22] Montoya J, Matta NB, Suchon P, Guzian MC, Lambert NC, Mattei JP, et alPatients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective study. Ann Rheum Dis 2016;75(5):879–82 link1
[23] Liu J, Kandasamy S, Zhang J, Kirby CW, Karakach T, Hafting J, et alPrebiotic effects of diet supplemented with the cultivated red seaweed Chondrus crispus or with fructo-oligo-saccharide on host immunity, colonic microbiota and gut microbial metabolites. BMC Complement Altern Med 2015;15:279 link1
[24] J?rgensen SF, Tr?seid M, Kummen M, Anmarkrud JA, Michelsen AE, Osnes LT, et alAltered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation. Mucosal Immunol 2016;9(6):1455–65 link1
[25] Farkas AM, Panea C, Goto Y, Nakato G, Galan-Diez M, Narushima S, et alInduction of Th17 cells by segmented filamentous bacteria in the murine intestine. J Immunol Methods 2015;421:104–11 link1
[26] Joyce SA, Gahan CG. Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health. Annu Rev Food Sci Technol 2016;7(1):313–33 link1
[27] Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature 2016;535(7610):65–74 link1
[28] Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature 2016;535(7610):75–84 link1
[29] Morris G, Berk M, Carvalho A, Caso JR, Sanz Y, Walder K, et alThe role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease. Mol Neurobiol.Epub 2016 Jun 27 link1
[30] Kim CH, Park J, Kim M. Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Netw 2014;14(6):277–88 link1
[31] Ohno H. Gut microbiota, host defense and immunity: analysis with integrative omics approach. Jpn J Clin Immunol 2014;37(5):403–11. Japanese link1
[32] Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly -Y M, et alThe microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341(6145):569–73 link1
[33] Ericsson AC, Hagan CE, Davis DJ, Franklin CL. Segmented filamentous bacteria: commensal microbes with potential effects on research. Comp Med 2014;64(2):90–8 link1
[34] Goto Y, Panea C, Nakato G, Cebula A, Lee C, Diez MG, et alSegmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 2014;40(4):594–607 link1
[35] Mansson I, Colldahl H. The intestinal flora in patients with bronchial asthma and rheumatoid arthritis. Acta Allergol 1965;20:94–104 link1
[36] Dearlove SM, Barr K, Neumann V, Isdale A, Bird HA, Gooi HC, et alThe effect of non-steroidal anti-inflammatory drugs on faecal flora and bacterial antibody levels in rheumatoid arthritis. Br J Rheumatol 1992;31(7):443–7 link1
[37] Kohashi O, Kuwata J, Umehara K, Uemura F, Takahashi T, Ozawa A. Susceptibility to adjuvant-induced arthritis among germfree, specific-pathogen-free, and conventional rats. Infect Immun 1979;26(3):791–4 link1
[38] Liu X, Zeng B, Zhang J, Li W, Mou F, Wang H, et alRole of the gut microbiome in modulating arthritis progression in mice. Sci Rep 2016;6:30594 link1
[39] Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66(5):365–78 link1
[40] Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis 2015;60(Suppl 2):S108–21 link1
[41] He B, Hoang TK, Wang T, Ferris M, Taylor CM, Tian X, et alResetting microbiota by Lactobacillus reuteri inhibits Treg deficiency-induced autoimmunity via adenosine A2A receptors. J Exp Med 2017;214(1):107–23. 27994068 link1
[42] Manuzak JA, Hensley-McBain T, Zevin AS, Miller C, Cubas R, Agricola B, et alEnhancement of microbiota in healthy macaques results in beneficial modulation of mucosal and systemic immune function. J Immunol 2016;196(5):2401–9 link1
[43] Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, et alLinking the human gut microbiome to inflammatory cytokine production capacity. Cell 2016;167(7):1897 link1
京公网安备 11010502051620号
